Published in J Bone Joint Surg Am on July 01, 2001
Trabecular Metal cups for acetabular defects with 50% or less host bone contact. Clin Orthop Relat Res (2009) 1.27
Risk factors for accelerated polyethylene wear and osteolysis in ABG I total hip arthroplasty. Int Orthop (2009) 1.12
Use of morphometry to quantify osteolysis after total hip arthroplasty. Clin Orthop Relat Res (2010) 1.10
Promising Mid-term Results With a Cup-cage Construct for Large Acetabular Defects and Pelvic Discontinuity. Clin Orthop Relat Res (2016) 1.08
Acetabular cage survival and analysis of factors related to failure. Clin Orthop Relat Res (2008) 1.02
Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet (2009) 1.00
Revision total hip arthroplasty with a porous-coated modular stem: 5 to 10 years follow-up. Clin Orthop Relat Res (2009) 0.99
Do Rerevision Rates Differ After First-time Revision of Primary THA With a Cemented and Cementless Femoral Component? Clin Orthop Relat Res (2015) 0.92
Early reactive synovitis and osteolysis after total hip arthroplasty. Clin Orthop Relat Res (2010) 0.91
Revision of the deficient proximal femur with a proximal femoral allograft. Clin Orthop Relat Res (2008) 0.90
Salvage of failed acetabular cages by nonbuttressed trabecular metal cups. Clin Orthop Relat Res (2009) 0.89
Modular femoral stems for revision total hip arthroplasty. Clin Orthop Relat Res (2011) 0.87
Reliability and validity of the Hartofilakidis classification system of congenital hip disease in adults. Int Orthop (2007) 0.87
Male gender, Charnley class C, and severity of bone defects predict the risk for aseptic loosening in the cup of ABG I hip arthroplasty. BMC Musculoskelet Disord (2010) 0.78
Management bone loss of the proximal femur in revision hip arthroplasty: Update on reconstructive options. World J Orthop (2014) 0.77
Multiple Acetabular Revisions in THA - Poor Outcome Despite Maximum Effort. Open Orthop J (2012) 0.77
Classifications In Brief: The Paprosky Classification of Femoral Bone Loss. Clin Orthop Relat Res (2016) 0.75
Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med (1997) 19.00
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med (1999) 10.94
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
What do we mean by partnership in making decisions about treatment? BMJ (1999) 5.31
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A (1997) 4.89
A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med (1992) 4.60
Controlling health expenditures--the Canadian reality. N Engl J Med (1989) 4.36
System for Health Area Resource Planning (SHARP): an application to Ontario medical school enrollment. CMAJ (1994) 4.11
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med (1997) 4.10
Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull World Health Organ (1979) 3.59
Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J Health Econ (1992) 3.33
Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making (1989) 3.26
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry (1998) 3.26
Health care contingent valuation studies: a review and classification of the literature. Health Econ (1998) 3.13
The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG (2011) 2.97
Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet (2001) 2.90
Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol (2001) 2.70
Universal precautions to prevent HIV transmission to health care workers: an economic analysis. CMAJ (1990) 2.68
In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res (2001) 2.62
Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ (1986) 2.57
Cost-effectiveness ratios: in a league of their own. Health Policy (1994) 2.55
Needle exchange programs: an economic evaluation of a local experience. CMAJ (1997) 2.46
Relation of infant mortality to the availability of maternity care in rural Florida. J Am Board Fam Pract (1995) 2.42
Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am (1996) 2.26
Cephalothin in serious bacterial infection. Ann Intern Med (1966) 2.25
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13
Joint infection by anaerobic bacteria: a case report and review of the literature. Arthritis Rheum (1969) 2.09
Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol (2000) 2.07
Caudal tramadol for postoperative analgesia in pediatric hypospadias surgery. Br J Anaesth (1997) 2.05
Analysis of fluorescence decay curves by means of the Laplace transformation. Biophys J (1975) 1.96
Allograft reconstruction of the acetabulum after resection of stage-IIB sarcoma. Intermediate-term results. J Bone Joint Surg Am (1997) 1.93
Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol (1996) 1.91
Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns (2013) 1.89
Discounting in the economic evaluation of health care interventions. Med Care (1993) 1.89
Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol (1997) 1.88
Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis (1991) 1.87
Audit of oxygen prescribing before and after the introduction of a prescription chart. BMJ (2000) 1.82
Protein kinase CK2 signal in neoplasia. Histol Histopathol (2001) 1.79
The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decis Making (1991) 1.73
Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: more effective and less expensive. Crit Care Med (2000) 1.71
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study. AIDS (1999) 1.70
Physician supply in Ontario: further observations on SHARP and the SHARP projections. CMAJ (1995) 1.67
Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol (1995) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Shared decision making in a publicly funded health care system. Policies exist to reduce the risk of conflict between individual and society. BMJ (1999) 1.65
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med (1997) 1.62
Epidemiology of permanent childhood hearing impairment in Trent Region, 1985-1993. Br J Audiol (1997) 1.61
Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer (1994) 1.60
Recognizing diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Health Econ (2001) 1.59
Recent advances in schistosomiasis. Q J Med (1986) 1.59
How to improve communication between doctors and patients. Learning more about the decision making context is important. BMJ (2000) 1.55
Newborn circumcision: an economic perspective. Can Med Assoc J (1984) 1.54
When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making (1996) 1.53
Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ (1989) 1.51
Occupational exposure to noise and the attributable burden of hearing difficulties in Great Britain. Occup Environ Med (2002) 1.51
Systematic review of the clinical and cost effectiveness of digital hearing aids. Br J Audiol (2001) 1.49
Nuclease B. A possible precursor of nuclease A, an extracellular nuclease of Staphylococcus aureus. J Biol Chem (1977) 1.47
Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest (1998) 1.47
The significance of low back pain in older adults. Can Med Assoc J (1976) 1.46
Failure of topical bupivacaine to relieve pain after vitreoretinal surgery. Eye (Lond) (1994) 1.45
Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care (1990) 1.44
Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol (1999) 1.42
Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther (2001) 1.42
Prenatal diagnosis. Lancet (1989) 1.42
Preoperative HIV testing: is it less expensive than universal precautions? J Clin Epidemiol (1993) 1.41
Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med (1992) 1.41
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res (2001) 1.40
A new practical back brace. Can Med Assoc J (1966) 1.40
Prevalence of Cysticercus bovis in Australian cattle. Aust Vet J (2010) 1.39
A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis of 11-nor-delta9-THC-9-COOH. J Anal Toxicol (1997) 1.39
Fresh osteochondral allografts for post-traumatic osteochondral defects of the knee. J Bone Joint Surg Br (1997) 1.39
Assessment of international medical evacuations in Macedonia. Lancet (1999) 1.39
Comparative trials of antimonial drugs in urinary schistosomiasis. Bull World Health Organ (1968) 1.38
Understanding economic evaluations: a review of the knee arthroplasty literature. Am J Knee Surg (1999) 1.38
Pediatric oncology in developing countries: development of an alliance of stakeholders. Med Pediatr Oncol (2001) 1.38
Frontal lobe volume in patients with Huntington's disease. Neurology (1998) 1.38
The impact of hearing impairment on television viewing in the UK. Br J Audiol (1993) 1.38
Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys (1995) 1.38
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Modifying the mouse: design and desire. Biotechnology (N Y) (1992) 1.36
The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer (1997) 1.35
In vitro synthesis of adenovirus type 5 T antigens. I. Translation of early region 1-specific rna from lytically infected cells. J Virol (1981) 1.35
Calcium requirement for assemby of the lipid-containing bacteriophage PM2. Biochim Biophys Acta (1974) 1.35
Hearing impairment in children after bacterial meningitis: incidence and resource implications. Br J Audiol (1993) 1.35
GO GIRLS!: results from a nutrition and physical activity program for low-income, overweight African American adolescent females. Health Educ Behav (2000) 1.34
Metrifonate in urinary schistosomiasis. Bull World Health Organ (1969) 1.34
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34
Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation. Cancer Lett (1996) 1.34
Outcomes and costs of coronary artery bypass grafting: comparison between octogenarians and septuagenarians at a tertiary care centre. CMAJ (2001) 1.33
The challenges of evaluating environmental interventions to increase population levels of physical activity: the case of the UK National Cycle Network. J Epidemiol Community Health (2003) 1.32
Elucidating the contributions of processing speed, executive ability, and frontal lobe volume to normal age-related differences in fluid intelligence. J Int Neuropsychol Soc (2000) 1.32
Immunogenicity of allograft articular cartilage. J Bone Joint Surg Am (1974) 1.31
Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg (1994) 1.29
Bordetella pertussis serotypes in the United States. Appl Microbiol (1969) 1.29
Chemotherapy waste reduction through shelf-life extension. Can J Hosp Pharm (1994) 1.29
Complications of total hip arthroplasty: MR imaging-initial experience. Radiology (2000) 1.29
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology (2001) 1.28